Literature DB >> 31791041

Lactobacilli-dominated cervical microbiota in women with preterm prelabor rupture of membranes.

Marian Kacerovsky1,2, Lenka Pliskova3, Radka Bolehovska3, Romana Gerychova4, Petr Janku4, Petr Matlak5, Ondrej Simetka5, Tomas Faist6, Jan Mls6, Petr Vescicik6, Helena Zemlickova7, Bo Jacobsson8,9,10, Ivana Musilova6.   

Abstract

BACKGROUND: To determine the association between microbial invasion of the amniotic cavity (MIAC) and the presence of Lactobacillus crispatus- or Lactobacillus iners-dominated cervical microbiota in pregnancies with preterm prelabor rupture of membrane. Next, to assess the relationship between the presence of L. crispatus- or L. iners-dominated cervical microbiota and short-term neonatal morbidity.
METHOD: A total of 311 women were included. Cervical samples were obtained using a Dacron polyester swab and amniotic fluid samples were obtained by transabdominal amniocentesis. Bacterial DNA, L. crispatus, and L. iners in the cervical samples were assessed by PCR. Cervical microbiota was assigned as L. crispatus- or L. iners-dominated when the relative abundance of L. crispatus or L. iners was ≥50% of the whole cervical microbiota, respectively.
RESULTS: Women with MIAC showed a lower rate of L. crispatus-dominated cervical microbiota (21% vs. 39%; p = 0.003) than those without MIAC. Lactobacillus crispatus-dominated cervical microbiota was associated with a lower rate of early-onset sepsis (0% vs. 5%; p = 0.02).
CONCLUSIONS: The presence of L. crispatus-dominated cervical microbiota in women with preterm prelabor rupture of membrane was associated with a lower risk of intra-amniotic complications and subsequent development of early-onset sepsis of newborns.

Entities:  

Mesh:

Year:  2019        PMID: 31791041     DOI: 10.1038/s41390-019-0692-1

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  3 in total

1.  Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranes.

Authors:  Daniel B DiGiulio; Roberto Romero; Juan Pedro Kusanovic; Ricardo Gómez; Chong Jai Kim; Kimberley S Seok; Francesca Gotsch; Shali Mazaki-Tovi; Edi Vaisbuch; Katherine Sanders; Elisabeth M Bik; Tinnakorn Chaiworapongsa; Enrique Oyarzún; David A Relman
Journal:  Am J Reprod Immunol       Date:  2010-03-21       Impact factor: 3.886

2.  The effect of transferrin and lysozyme on antibacterial activity of amniotic fluid.

Authors:  K Oka; Y Hagio; M Tetsuoh; K Kawano; T Hamada; T Kato
Journal:  Biol Res Pregnancy Perinatol       Date:  1987

Review 3.  Preterm premature rupture of the membranes.

Authors:  Brian M Mercer
Journal:  Obstet Gynecol       Date:  2003-01       Impact factor: 7.661

  3 in total
  9 in total

1.  Tumor microbial diversity and compositional differences among women in Botswana with high-grade cervical dysplasia and cervical cancer.

Authors:  Travis T Sims; Greyson W G Biegert; Doreen Ramogola-Masire; Kebatshabile Ngoni; Travis Solley; Matthew S Ning; Molly B El Alam; Melissa Mezzari; Joseph Petrosino; Nicola M Zetola; Kathleen M Schmeler; Lauren E Colbert; Ann H Klopp; Surbhi Grover
Journal:  Int J Gynecol Cancer       Date:  2020-07-16       Impact factor: 3.437

2.  Prevalence and Load of Cervical Ureaplasma Species With Respect to Intra-amniotic Complications in Women With Preterm Prelabor Rupture of Membranes Before 34 weeks.

Authors:  Marian Kacerovsky; Rudolf Kukla; Radka Bolehovska; Pavel Bostik; Jana Matulova; Jan Mls; Jaroslav Stranik; Bo Jacobsson; Ivana Musilova
Journal:  Front Pharmacol       Date:  2022-03-31       Impact factor: 5.810

3.  Association of COVID-19 with pregnancy outcomes in health-care workers and general women.

Authors:  S Khan; L Jun; R Siddique; Y Li; G Han; M Xue; G Nabi; J Liu
Journal:  Clin Microbiol Infect       Date:  2020-04-08       Impact factor: 8.067

4.  Comprehensive proteomic investigation of infectious and inflammatory changes in late preterm prelabour rupture of membranes.

Authors:  Marie Vajrychová; Jaroslav Stráník; Kristýna Pimková; Malin Barman; Rudolf Kukla; Petra Zedníková; Radka Bolehovská; Lenka Plíšková; Helena Hornychová; Ctirad Andrýs; Vojtěch Tambor; Juraj Lenčo; Bo Jacobsson; Marian Kacerovský
Journal:  Sci Rep       Date:  2020-10-19       Impact factor: 4.379

5.  Cervical Gardnerella vaginalis in women with preterm prelabor rupture of membranes.

Authors:  Marian Kacerovsky; Lenka Pliskova; Radka Bolehovska; Daniel Lesko; Romana Gerychova; Petr Janku; Petr Matlak; Ondrej Simetka; Jaroslav Stranik; Tomas Faist; Jan Mls; Peter Vescicik; Bo Jacobsson; Ivana Musilova
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

Review 6.  Gut and Reproductive Tract Microbiota Adaptation during Pregnancy: New Insights for Pregnancy-Related Complications and Therapy.

Authors:  Martina De Siena; Lucrezia Laterza; Maria Valeria Matteo; Irene Mignini; Tommaso Schepis; Gianenrico Rizzatti; Gianluca Ianiro; Emanuele Rinninella; Marco Cintoni; Antonio Gasbarrini
Journal:  Microorganisms       Date:  2021-02-25

7.  Prenatal inflammation as a link between placental expression signature of tryptophan metabolism and preterm birth.

Authors:  Rona Karahoda; Morgane Robles; Julia Marushka; Jaroslav Stranik; Cilia Abad; Hana Horackova; Jurjen Duintjer Tebbens; Cathy Vaillancourt; Marian Kacerovsky; Frantisek Staud
Journal:  Hum Mol Genet       Date:  2021-11-01       Impact factor: 6.150

Review 8.  Breaking Down the Barrier: The Role of Cervical Infection and Inflammation in Preterm Birth.

Authors:  Ourlad Alzeus G Tantengco; Ramkumar Menon
Journal:  Front Glob Womens Health       Date:  2022-01-18

9.  Clinical characteristics of colonization of the amniotic cavity in women with preterm prelabor rupture of membranes, a retrospective study.

Authors:  Marian Kacerovsky; Jaroslav Stranik; Jana Matulova; Martina Chalupska; Jan Mls; Tomáš Faist; Helena Hornychova; Rudolf Kukla; Radka Bolehovska; Pavel Bostik; Bo Jacobsson; Ivana Musilova
Journal:  Sci Rep       Date:  2022-03-24       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.